Gefitinib Reverses TRAIL Resistance in Human Bladder Cancer Cell Lines via Inhibition of AKT-Mediated X-Linked Inhibitor of Apoptosis Protein Expression
Cancer Research - United States
doi 10.1158/0008-5472.can-06-1224
Full Text
Open PDFAbstract
Available in full text
Date
February 15, 2007
Authors
Publisher
American Association for Cancer Research (AACR)